Conjunctivitis Does Not Increase With Longer Duration of Lebrikizumab Exposure in Patients With Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s276, 2023. DOI: 10.25251/skin.7.supp.276. Disponível em: https://skin.dermsquared.com/skin/article/view/2386. Acesso em: 18 apr. 2026.